狭心症の世界市場 2020年：企業別、地域別、種類・用途別

• 英文タイトル：Global Angina Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：D0804-14729 • 出版社/出版日：GlobalInfoResearch / 2020年7月21日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、101ページ • 納品方法：Eメール • 産業分類：医療

• 販売価格（消費税別）

Single User	￥487,200 (USD3,480)	▷ お問い合わせ
Multi User	￥730,800 (USD5,220)	▷ お問い合わせ
Corporate User	￥974,400 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、狭心症の世界市場を広く調査・分析し、今後の市場展望をまとめております。狭心症の種類別市場規模（ベータ遮断薬、カルシウム拮抗薬、抗凝固剤、抗血小板剤、硝酸塩、ACE阻害剤、ラノラジン）、用途別市場規模（クリニック、病院、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Amgen、Kuhnil Pharmaceutical、Lee’s Pharmaceutical、Taxus Cardium Pharmaceuticals、ViroMed、LegoChem Biosciences、Juventas Therapeutics、Milestone Pharmaceuticals ・地域別グローバル市場分析 2015年-2020年 ・狭心症の北米市場（アメリカ、カナダ、メキシコ） ・狭心症のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・狭心症のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・狭心症の南米市場（ブラジル、アルゼンチン） ・狭心症の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ベータ遮断薬、カルシウム拮抗薬、抗凝固剤、抗血小板剤、硝酸塩、ACE阻害剤、ラノラジン ・用途別分析：クリニック、病院、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論

Market Overview
The global Angina market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.9% in the forecast period of 2020 to 2025 and will expected to reach USD 12300 million by 2025, from USD 10550 million in 2019.

The Angina market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Angina market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Angina market has been segmented into:
Beta Blockers
Calcium Antagonists
Anticoagulants
Antiplatelet
Nitrates
ACE inhibitors
Ranolazine

By Application, Angina has been segmented into:
Clinics
Hospitals
Other

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Angina market presented in the report. This section sheds light on the sales growth of different regional and country-level Angina markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Angina market.

The report offers in-depth assessment of the growth and other aspects of the Angina market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Angina Market Share Analysis
Angina competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Angina sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Angina sales, revenue and market share for each player covered in this report.

The major players covered in Angina are:
Amgen
Kuhnil Pharmaceutical
Lee’s Pharmaceutical
Taxus Cardium Pharmaceuticals
ViroMed
LegoChem Biosciences
Juventas Therapeutics
Milestone Pharmaceuticals

レポート目次

---

Table of Contents

1 Angina Market Overview
1.1 Product Overview and Scope of Angina
1.2 Classification of Angina by Type
1.2.1 Global Angina Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Angina Revenue Market Share by Type in 2019
1.2.3 Beta Blockers
1.2.4 Calcium Antagonists
1.2.5 Anticoagulants
1.2.6 Antiplatelet
1.2.7 Nitrates
1.2.8 ACE inhibitors
1.2.9 Ranolazine
1.3 Global Angina Market by Application
1.3.1 Overview: Global Angina Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Other
1.4 Global Angina Market by Regions
1.4.1 Global Angina Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Angina (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Angina Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Angina Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Angina Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Angina Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Angina Status and Prospect (2015-2025)
2 Company Profiles
2.1 Amgen
2.1.1 Amgen Details
2.1.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Amgen SWOT Analysis
2.1.4 Amgen Product and Services
2.1.5 Amgen Angina Revenue, Gross Margin and Market Share (2018-2019)
2.2 Kuhnil Pharmaceutical
2.2.1 Kuhnil Pharmaceutical Details
2.2.2 Kuhnil Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Kuhnil Pharmaceutical SWOT Analysis
2.2.4 Kuhnil Pharmaceutical Product and Services
2.2.5 Kuhnil Pharmaceutical Angina Revenue, Gross Margin and Market Share (2018-2019)
2.3 Lee’s Pharmaceutical
2.3.1 Lee’s Pharmaceutical Details
2.3.2 Lee’s Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Lee’s Pharmaceutical SWOT Analysis
2.3.4 Lee’s Pharmaceutical Product and Services
2.3.5 Lee’s Pharmaceutical Angina Revenue, Gross Margin and Market Share (2018-2019)
2.4 Taxus Cardium Pharmaceuticals
2.4.1 Taxus Cardium Pharmaceuticals Details
2.4.2 Taxus Cardium Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Taxus Cardium Pharmaceuticals SWOT Analysis
2.4.4 Taxus Cardium Pharmaceuticals Product and Services
2.4.5 Taxus Cardium Pharmaceuticals Angina Revenue, Gross Margin and Market Share (2018-2019)
2.5 ViroMed
2.5.1 ViroMed Details
2.5.2 ViroMed Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 ViroMed SWOT Analysis
2.5.4 ViroMed Product and Services
2.5.5 ViroMed Angina Revenue, Gross Margin and Market Share (2018-2019)
2.6 LegoChem Biosciences
2.6.1 LegoChem Biosciences Details
2.6.2 LegoChem Biosciences Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 LegoChem Biosciences SWOT Analysis
2.6.4 LegoChem Biosciences Product and Services
2.6.5 LegoChem Biosciences Angina Revenue, Gross Margin and Market Share (2018-2019)
2.7 Juventas Therapeutics
2.7.1 Juventas Therapeutics Details
2.7.2 Juventas Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Juventas Therapeutics SWOT Analysis
2.7.4 Juventas Therapeutics Product and Services
2.7.5 Juventas Therapeutics Angina Revenue, Gross Margin and Market Share (2018-2019)
2.8 Milestone Pharmaceuticals
2.8.1 Milestone Pharmaceuticals Details
2.8.2 Milestone Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Milestone Pharmaceuticals SWOT Analysis
2.8.4 Milestone Pharmaceuticals Product and Services
2.8.5 Milestone Pharmaceuticals Angina Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Angina Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Angina Players Market Share
3.2.2 Top 10 Angina Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Angina Revenue and Market Share by Regions
4.2 North America Angina Revenue and Growth Rate (2015-2020)
4.3 Europe Angina Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Angina Revenue and Growth Rate (2015-2020)
4.5 South America Angina Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Angina Revenue and Growth Rate (2015-2020)
5 North America Angina Revenue by Countries
5.1 North America Angina Revenue by Countries (2015-2020)
5.2 USA Angina Revenue and Growth Rate (2015-2020)
5.3 Canada Angina Revenue and Growth Rate (2015-2020)
5.4 Mexico Angina Revenue and Growth Rate (2015-2020)
6 Europe Angina Revenue by Countries
6.1 Europe Angina Revenue by Countries (2015-2020)
6.2 Germany Angina Revenue and Growth Rate (2015-2020)
6.3 UK Angina Revenue and Growth Rate (2015-2020)
6.4 France Angina Revenue and Growth Rate (2015-2020)
6.5 Russia Angina Revenue and Growth Rate (2015-2020)
6.6 Italy Angina Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Angina Revenue by Countries
7.1 Asia-Pacific Angina Revenue by Countries (2015-2020)
7.2 China Angina Revenue and Growth Rate (2015-2020)
7.3 Japan Angina Revenue and Growth Rate (2015-2020)
7.4 Korea Angina Revenue and Growth Rate (2015-2020)
7.5 India Angina Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Angina Revenue and Growth Rate (2015-2020)
8 South America Angina Revenue by Countries
8.1 South America Angina Revenue by Countries (2015-2020)
8.2 Brazil Angina Revenue and Growth Rate (2015-2020)
8.3 Argentina Angina Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Angina by Countries
9.1 Middle East & Africa Angina Revenue by Countries (2015-2020)
9.2 Saudi Arabia Angina Revenue and Growth Rate (2015-2020)
9.3 UAE Angina Revenue and Growth Rate (2015-2020)
9.4 Egypt Angina Revenue and Growth Rate (2015-2020)
9.5 South Africa Angina Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Angina Revenue and Market Share by Type (2015-2020)
10.2 Global Angina Market Forecast by Type (2019-2024)
10.3 Beta Blockers Revenue Growth Rate (2015-2025)
10.4 Calcium Antagonists Revenue Growth Rate (2015-2025)
10.5 Anticoagulants Revenue Growth Rate (2015-2025)
10.6 Antiplatelet Revenue Growth Rate (2015-2025)
10.7 Nitrates Revenue Growth Rate (2015-2025)
10.8 ACE inhibitors Revenue Growth Rate (2015-2025)
10.9 Ranolazine Revenue Growth Rate (2015-2025)
11 Global Angina Market Segment by Application
11.1 Global Angina Revenue Market Share by Application (2015-2020)
11.2 Angina Market Forecast by Application (2019-2024)
11.3 Clinics Revenue Growth (2015-2020)
11.4 Hospitals Revenue Growth (2015-2020)
11.5 Other Revenue Growth (2015-2020)
12 Global Angina Market Size Forecast (2021-2025)
12.1 Global Angina Market Size Forecast (2021-2025)
12.2 Global Angina Market Forecast by Regions (2021-2025)
12.3 North America Angina Revenue Market Forecast (2021-2025)
12.4 Europe Angina Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Angina Revenue Market Forecast (2021-2025)
12.6 South America Angina Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Angina Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Angina Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Angina by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Angina Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Angina Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Amgen Corporate Information, Location and Competitors
Table 6. Amgen Angina Major Business
Table 7. Amgen Angina Total Revenue (USD Million) (2017-2018)
Table 8. Amgen SWOT Analysis
Table 9. Amgen Angina Product and Solutions
Table 10. Amgen Angina Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Kuhnil Pharmaceutical Corporate Information, Location and Competitors
Table 12. Kuhnil Pharmaceutical Angina Major Business
Table 13. Kuhnil Pharmaceutical Angina Total Revenue (USD Million) (2018-2019)
Table 14. Kuhnil Pharmaceutical SWOT Analysis
Table 15. Kuhnil Pharmaceutical Angina Product and Solutions
Table 16. Kuhnil Pharmaceutical Angina Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Lee’s Pharmaceutical Corporate Information, Location and Competitors
Table 18. Lee’s Pharmaceutical Angina Major Business
Table 19. Lee’s Pharmaceutical Angina Total Revenue (USD Million) (2017-2018)
Table 20. Lee’s Pharmaceutical SWOT Analysis
Table 21. Lee’s Pharmaceutical Angina Product and Solutions
Table 22. Lee’s Pharmaceutical Angina Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Taxus Cardium Pharmaceuticals Corporate Information, Location and Competitors
Table 24. Taxus Cardium Pharmaceuticals Angina Major Business
Table 25. Taxus Cardium Pharmaceuticals Angina Total Revenue (USD Million) (2017-2018)
Table 26. Taxus Cardium Pharmaceuticals SWOT Analysis
Table 27. Taxus Cardium Pharmaceuticals Angina Product and Solutions
Table 28. Taxus Cardium Pharmaceuticals Angina Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. ViroMed Corporate Information, Location and Competitors
Table 30. ViroMed Angina Major Business
Table 31. ViroMed Angina Total Revenue (USD Million) (2017-2018)
Table 32. ViroMed SWOT Analysis
Table 33. ViroMed Angina Product and Solutions
Table 34. ViroMed Angina Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. LegoChem Biosciences Corporate Information, Location and Competitors
Table 36. LegoChem Biosciences Angina Major Business
Table 37. LegoChem Biosciences Angina Total Revenue (USD Million) (2017-2018)
Table 38. LegoChem Biosciences SWOT Analysis
Table 39. LegoChem Biosciences Angina Product and Solutions
Table 40. LegoChem Biosciences Angina Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Juventas Therapeutics Corporate Information, Location and Competitors
Table 42. Juventas Therapeutics Angina Major Business
Table 43. Juventas Therapeutics Angina Total Revenue (USD Million) (2017-2018)
Table 44. Juventas Therapeutics SWOT Analysis
Table 45. Juventas Therapeutics Angina Product and Solutions
Table 46. Juventas Therapeutics Angina Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Milestone Pharmaceuticals Corporate Information, Location and Competitors
Table 48. Milestone Pharmaceuticals Angina Major Business
Table 49. Milestone Pharmaceuticals Angina Total Revenue (USD Million) (2017-2018)
Table 50. Milestone Pharmaceuticals SWOT Analysis
Table 51. Milestone Pharmaceuticals Angina Product and Solutions
Table 52. Milestone Pharmaceuticals Angina Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Global Angina Revenue (Million USD) by Players (2015-2020)
Table 54. Global Angina Revenue Share by Players (2015-2020)
Table 55. Global Angina Revenue (Million USD) by Regions (2015-2020)
Table 56. Global Angina Revenue Market Share by Regions (2015-2020)
Table 57. North America Angina Revenue by Countries (2015-2020)
Table 58. North America Angina Revenue Market Share by Countries (2015-2020)
Table 59. Europe Angina Revenue (Million USD) by Countries (2015-2020)
Table 60. Asia-Pacific Angina Revenue (Million USD) by Countries (2015-2020)
Table 61. South America Angina Revenue by Countries (2015-2020)
Table 62. South America Angina Revenue Market Share by Countries (2015-2020)
Table 63. Middle East and Africa Angina Revenue (Million USD) by Countries (2015-2020)
Table 64. Middle East and Africa Angina Revenue Market Share by Countries (2015-2020)
Table 65. Global Angina Revenue (Million USD) by Type (2015-2020)
Table 66. Global Angina Revenue Share by Type (2015-2020)
Table 67. Global Angina Revenue Forecast by Type (2021-2025)
Table 68. Global Angina Revenue by Application (2015-2020)
Table 69. Global Angina Revenue Share by Application (2015-2020)
Table 70. Global Angina Revenue Forecast by Application (2021-2025)
Table 71. Global Angina Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Angina Picture
Figure 2. Global Angina Revenue Market Share by Type in 2019
Figure 3. Beta Blockers Picture
Figure 4. Calcium Antagonists Picture
Figure 5. Anticoagulants Picture
Figure 6. Antiplatelet Picture
Figure 7. Nitrates Picture
Figure 8. ACE inhibitors Picture
Figure 9. Ranolazine Picture
Figure 10. Angina Revenue Market Share by Application in 2019
Figure 11. Clinics Picture
Figure 12. Hospitals Picture
Figure 13. Other Picture
Figure 14. Global Angina Revenue (USD Million) and Growth Rate (2015-2025)
Figure 15. North America Angina Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Europe Angina Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Asia-Pacific Angina Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. South America Angina Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Middle East and Africa Angina Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Angina Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Global Angina Revenue Share by Players in 2019
Figure 22. Global Top 5 Players Angina Revenue Market Share in 2019
Figure 23. Global Top 10 Players Angina Revenue Market Share in 2019
Figure 24. Key Players Market Share Trend
Figure 25. Global Angina Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 26. Global Angina Revenue Market Share by Regions (2015-2020)
Figure 27. Global Angina Revenue Market Share by Regions in 2018
Figure 28. North America Angina Revenue and Growth Rate (2015-2020)
Figure 29. Europe Angina Revenue and Growth Rate (2015-2020)
Figure 30. Asia-Pacific Angina Revenue and Growth Rate (2015-2020)
Figure 31. South America Angina Revenue and Growth Rate (2015-2020)
Figure 32. Middle East and Africa Angina Revenue and Growth Rate (2015-2020)
Figure 33. North America Angina Revenue Market Share by Countries (2015-2020)
Figure 34. North America Angina Revenue Market Share by Countries in 2019
Figure 35. USA Angina Revenue and Growth Rate (2015-2020)
Figure 36. Canada Angina Revenue and Growth Rate (2015-2020)
Figure 37. Mexico Angina Revenue and Growth Rate (2015-2020)
Figure 38. Europe Angina Revenue Market Share by Countries (2015-2020)
Figure 39. Europe Angina Revenue Market Share by Countries in 2019
Figure 40. Germany Angina Revenue and Growth Rate (2015-2020)
Figure 41. UK Angina Revenue and Growth Rate (2015-2020)
Figure 42. France Angina Revenue and Growth Rate (2015-2020)
Figure 43. Russia Angina Revenue and Growth Rate (2015-2020)
Figure 44. Italy Angina Revenue and Growth Rate (2015-2020)
Figure 45. Asia-Pacific Angina Revenue Market Share by Countries (2015-2020)
Figure 46. Asia-Pacific Angina Revenue Market Share by Countries in 2019
Figure 47. China Angina Revenue and Growth Rate (2015-2020)
Figure 48. Japan Angina Revenue and Growth Rate (2015-2020)
Figure 49. Korea Angina Revenue and Growth Rate (2015-2020)
Figure 50. India Angina Revenue and Growth Rate (2015-2020)
Figure 51. Southeast Asia Angina Revenue and Growth Rate (2015-2020)
Figure 52. South America Angina Revenue Market Share by Countries (2015-2020)
Figure 53. South America Angina Revenue Market Share by Countries in 2019
Figure 54. Brazil Angina Revenue and Growth Rate (2015-2020)
Figure 55. Argentina Angina Revenue and Growth Rate (2015-2020)
Figure 56. Middle East and Africa Angina Revenue Market Share by Countries (2015-2020)
Figure 57. Middle East and Africa Angina Revenue Market Share by Countries in 2019
Figure 58. Saudi Arabia Angina Revenue and Growth Rate (2015-2020)
Figure 59. UAE Angina Revenue and Growth Rate (2015-2020)
Figure 60. Egypt Angina Revenue and Growth Rate (2015-2020)
Figure 61. South Africa Angina Revenue and Growth Rate (2015-2020)
Figure 62. Global Angina Revenue Share by Type (2015-2020)
Figure 63. Global Angina Revenue Share by Type in 2019
Figure 64. Global Angina Market Share Forecast by Type (2021-2025)
Figure 65. Global Beta Blockers Revenue Growth Rate (2015-2020)
Figure 66. Global Calcium Antagonists Revenue Growth Rate (2015-2020)
Figure 67. Global Anticoagulants Revenue Growth Rate (2015-2020)
Figure 68. Global Antiplatelet Revenue Growth Rate (2015-2020)
Figure 69. Global Nitrates Revenue Growth Rate (2015-2020)
Figure 70. Global ACE inhibitors Revenue Growth Rate (2015-2020)
Figure 71. Global Ranolazine Revenue Growth Rate (2015-2020)
Figure 72. Global Angina Revenue Share by Application (2015-2020)
Figure 73. Global Angina Revenue Share by Application in 2019
Figure 74. Global Angina Market Share Forecast by Application (2021-2025)
Figure 75. Global Clinics Revenue Growth Rate (2015-2020)
Figure 76. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 77. Global Other Revenue Growth Rate (2015-2020)
Figure 78. Global Angina Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 79. Global Angina Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 80. Global Angina Revenue Market Share Forecast by Regions (2021-2025)
Figure 81. North America Angina Revenue Market Forecast (2021-2025)
Figure 82. Europe Angina Revenue Market Forecast (2021-2025)
Figure 83. Asia-Pacific Angina Revenue Market Forecast (2021-2025)
Figure 84. South America Angina Revenue Market Forecast (2021-2025)
Figure 85. Middle East and Africa Angina Revenue Market Forecast (2021-2025)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel

---